[
  {
    "date": "2023-12-30",
    "symbol": "VIRX",
    "period": "FY",
    "netincomeloss": -51058000,
    "rule10b51arradoptedflag": "false",
    "nonrule10b51arradoptedflag": "false",
    "rule10b51arrtrmntdflag": "false",
    "nonrule10b51arrtrmntdflag": "false",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "VIRACTA THERAPEUTICS, INC.",
    "entitycentralindexkey": 1061027,
    "entitycurrentreportingstatus": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityfilenumber": "000-51531",
    "entitytaxidentificationnumber": "94-3295878",
    "entityaddressaddressline1": "2533 S. Coast Hwy. 101, Suite 210",
    "entityaddresscityortown": "Cardiff",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92007,
    "cityareacode": 858,
    "localphonenumber": "400-8470",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityinteractivedatacurrent": "Yes",
    "entityincorporationstatecountrycode": "DE",
    "tradingsymbol": "VIRX",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "securityexchangename": "NASDAQ",
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "San Diego, California",
    "auditorfirmid": 42,
    "documentfinstmterrorcorrectionflag": "false",
    "cashandcashequivalentsatcarryingvalue": 12317000,
    "shortterminvestments": 41374000,
    "prepaidexpenseandotherassetscurrent": 1273000,
    "assetscurrent": 54964000,
    "propertyplantandequipmentnet": 190000,
    "operatingleaserightofuseasset": 274000,
    "otherassetsnoncurrent": 1264000,
    "assets": 56692000,
    "accountspayablecurrent": 2441000,
    "accruedliabilitiescurrent": 10376000,
    "operatingleaseliabilitycurrent": 282000,
    "otherlongtermdebtcurrent": 25274000,
    "liabilitiescurrent": 38373000,
    "liabilities": 38373000,
    "preferredstockvalue": 5452000,
    "commonstockvalue": 4000,
    "additionalpaidincapital": 278786000,
    "accumulatedothercomprehensiveincomelossnetoftax": 9000,
    "retainedearningsaccumulateddeficit": -265932000,
    "stockholdersequity": 18319000,
    "liabilitiesandstockholdersequity": 56692000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "preferredstocksharesissued": 10248,
    "preferredstocksharesoutstanding": 10248,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 400000000,
    "commonstocksharesissued": 39093509,
    "commonstocksharesoutstanding": 39093509,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 33369000,
    "generalandadministrativeexpense": 17324000,
    "operatingexpenses": 50693000,
    "operatingincomeloss": -50693000,
    "interestincomeother": 3345000,
    "interestexpense": 3704000,
    "othernonoperatinggainslosses": -6000,
    "othernonoperatingincomeexpense": -365000,
    "unrealizedgainlossoninvestments": 187000,
    "comprehensiveincomenetoftax": -50871000,
    "earningspersharebasic": -1.32,
    "earningspersharediluted": -1.32,
    "weightedaveragenumberofsharesoutstandingbasic": 38624462,
    "weightedaveragenumberofdilutedsharesoutstanding": 38624462,
    "sharesissued": 10,
    "stockissuedduringperiodvaluestockoptionsexercised": 139000,
    "stockissuedduringperiodsharesstockoptionsexercised": 192,
    "stockissuedduringperiodsharesother": 372,
    "stockissuedduringperiodvalueother": 299000,
    "vestingofrestrictedstockunitsshares": 185,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 7649000,
    "sharebasedcompensation": 7649000,
    "depreciationdepletionandamortization": 492000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 2054000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -1431000,
    "increasedecreaseinotheroperatingassets": -566000,
    "increasedecreaseinaccountspayable": -98000,
    "increasedecreaseinaccruedliabilities": 3184000,
    "increasedecreaseinleaseliabilities1": -4000,
    "netcashprovidedbyusedinoperatingactivities": -39892000,
    "paymentstoacquirepropertyplantandequipment": 138000,
    "paymentstoacquireshortterminvestments": 67136000,
    "proceedsfromsalematurityandcollectionofshortterminvestments": 82272000,
    "netcashprovidedbyusedininvestingactivities": 14998000,
    "proceedsfromissuanceofcommonstock": 299000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 139000,
    "netcashprovidedbyusedinfinancingactivities": 438000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -24456000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 12317000,
    "interestpaidnet": 3070000,
    "interestandotherincome": 3344000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 381000,
    "workingcapital": 16600000,
    "cashcashequivalentsandshortterminvestments": 53700000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 9535000,
    "availableforsaledebtsecuritiesgrossunrealizedgain": 8000,
    "availableforsaledebtsecuritiesgrossunrealizedloss": 13000,
    "debtsecuritiesavailableforsalegainloss": 9535000,
    "cashandcashequivalentsfairvaluedisclosure": 9535000,
    "investmentsfairvaluedisclosure": 11379000,
    "assetsfairvaluedisclosure": 51408000,
    "numberofreportablesegments": 1,
    "debtsecuritiesavailableforsaleaccruedinterestafterallowanceforcreditloss": 100000,
    "debtsecuritiesavailableforsaleaccruedinterestafterallowanceforcreditlossstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent",
    "thirdpartyservicepercentage": 0.239,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 292799,
    "prepaidexpensecurrentandnoncurrent": 276000,
    "ercreceivable": 168000,
    "prepaidinsurance": 581000,
    "depositsassetscurrent": 135000,
    "accruedinterestreceivable": 113000,
    "prepaidexpensecurrent": 1273000,
    "employeerelatedliabilitiescurrent": 3374000,
    "accruedclinicaltrialandcontractexpenses": 6456000,
    "accruedprofessionalfeescurrent": 258000,
    "otheraccruedliabilitiescurrent": 288000,
    "otherassetscurrent": 600000,
    "lineofcreditfacilityborrowingcapacitydescription": "The second tranche of $20.0 million was drawn by the Company on December 29, 2022. The availability of the additional tranche of $25.0 million, previously available under certain conditions, expired on December 31, 2023.",
    "debtinstrumentinterestrateduringperiod": 0.0815,
    "debtinstrumentinterestratestatedpercentage": 0.049,
    "lineofcreditfacilityadditionalborrowingcapacity": 25000000,
    "debtinstrumentfinalpaymentinterestfeepercentage": 0.05,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 8571000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 8571000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 7858000,
    "aggregateminimumpaymentsunderdebtarrangements": 25000000,
    "debtinstrumentperiodicpaymenttermsballoonpaymenttobepaid": 397000,
    "unamortizeddiscountoffutureminimumpaymentsunderlongtermdebtarrangement": 123000,
    "longtermdebtcurrent": 25274000,
    "sharesissuedpricepershare": 500,
    "convertiblepreferredstocksharesissueduponconversion": 18811552,
    "stockoptionsgranted": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 1.17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 658955,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharesissuedconvertiblesharesconvertiblepricepershare": 17.5,
    "classofwarrantorrightissuedinperiodofwarrantsorrights": 250323,
    "classofwarrantorrightissuedremainunexercised": 86209,
    "classofwarrantorrightexpiryperiodofwarrantsorrights": "P7Y",
    "increaseinauthorizedcapital": 1375000,
    "percentageofnonqualifiedoptionsexercisablepriceoffairmarketvalueofcommonstock": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 0.83,
    "proceedsfromissuanceorsaleofequity": 47300000,
    "commonstockcapitalsharesreservedforfutureissuance": 292799,
    "allocatedsharebasedcompensationexpense": 2574000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P2Y2M12D",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 10900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonvestedoptionsoutstandingweightedaverageremainingcontractualterm": "P1Y4M24D",
    "percentageofcommonstockoutstanding": 0.0998,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0337,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.869,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 9350,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 3176,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 1010,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 4348,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 9350,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.55,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.9,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 4.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 5.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 4.35,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P8Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 1000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 18000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 1000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 247,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 185,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 51,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 3.58,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 4.06,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 8.16,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P0Y9M18D",
    "operatingleaseliability": 282000,
    "operatingleaseexpense": 400000,
    "operatingleaseleaseincomeleasepayments": 400,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 294000,
    "lesseeoperatingleaseliabilitypaymentsdue": 294000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 12000,
    "operatingleaseweightedaveragediscountratepercent": 0.148,
    "operatingleaseweightedaverageremainingleaseterm1": "P0Y8M12D",
    "operatinglosscarryforwards": 188200000,
    "researchtaxcreditcarryforwards": 1500000,
    "operatinglosscarryforwardsexpirationyearstart": 2027,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "valuationallowancedeferredtaxassetchangeinamount": 12500000,
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 147900000,
    "orphandrugcreditcarryforwards": 13600000,
    "researchcreditcarryforwardsexpirationyearstart": 2027,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 45942000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 11987000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 2297000,
    "deferredtaxassetsinprocessresearchanddevelopment": 3274000,
    "section174capitalizedrdexpenditures": 9717000,
    "deferredtaxassetsother": 57000,
    "deferredtaxassetsgross": 73274000,
    "rouasset": -58000,
    "deferredincometaxliabilities": 58000,
    "netdeferredtaxassetsbeforevaluationallowance": 73216000,
    "deferredtaxassetsvaluationallowance": 73216000,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.25,
    "effectiveincometaxrategeneralbusinesscredits": 0.06,
    "effectiveincometaxratereconciliationotheradjustments": -0.02,
    "unrecognizedtaxbenefits": 6779000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 998000
  },
  {
    "date": "2022-12-30",
    "symbol": "VIRX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "VIRACTA THERAPEUTICS, INC.",
    "entitycentralindexkey": 1061027,
    "entitycurrentreportingstatus": "Yes ",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No ",
    "entityvoluntaryfilers": "No ",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityfilenumber": "000-51531",
    "entitytaxidentificationnumber": "94-3295878",
    "entityaddressaddressline1": "2533 S. Coast Hwy. 101, Suite 210",
    "entityaddresscityortown": "Cardiff",
    "entityaddressstateorprovince": "California",
    "entityaddresspostalzipcode": 92007,
    "cityareacode": 858,
    "localphonenumber": "400-8470",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityinteractivedatacurrent": "Yes ",
    "entityincorporationstatecountrycode": "Delaware",
    "tradingsymbol": "VIRX",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "securityexchangename": "The Nasdaq Stock Market LLC",
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "San Diego, California",
    "auditorfirmid": 42,
    "cashandcashequivalentsatcarryingvalue": 36773000,
    "shortterminvestments": 54270000,
    "prepaidexpenseandotherassetscurrent": 2704000,
    "assetscurrent": 93747000,
    "propertyplantandequipmentnet": 148000,
    "operatingleaserightofuseasset": 300000,
    "otherassetsnoncurrent": 1830000,
    "assets": 95991000,
    "accountspayablecurrent": 2540000,
    "accruedliabilitiescurrent": 7193000,
    "operatingleaseliabilitycurrent": 278000,
    "liabilitiescurrent": 10011000,
    "longtermdebtnoncurrent": 24877000,
    "preferredstockvalue": 5452000,
    "commonstockvalue": 4000,
    "additionalpaidincapital": 270699000,
    "accumulatedothercomprehensiveincomelossnetoftax": -178000,
    "retainedearningsaccumulateddeficit": -214874000,
    "stockholdersequity": -214874000,
    "liabilitiesandstockholdersequity": 95991000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": "null",
    "preferredstocksharesissued": 10248,
    "preferredstocksharesoutstanding": 8333,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": 564125,
    "commonstocksharesoutstanding": "null",
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 26262000,
    "generalandadministrativeexpense": 24327000,
    "operatingexpenses": 50589000,
    "operatingincomeloss": -50589000,
    "interestincomeother": 1171000,
    "interestexpense": 577000,
    "othernonoperatinggainslosses": 798000,
    "othernonoperatingincomeexpense": 1392000,
    "netincomeloss": -49197000,
    "unrealizedgainlossoninvestments": -178000,
    "comprehensiveincomenetoftax": -49375000,
    "earningspersharebasic": -1.3,
    "earningspersharediluted": -1.3,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "sharesissued": 50329,
    "stockissuedduringperiodvaluestockoptionsexercised": 225000,
    "stockissuedduringperiodsharesstockoptionsexercised": 105000,
    "stockissuedduringperiodsharesother": 564,
    "stockissuedduringperiodvalueother": 2331000,
    "vestingofrestrictedstockunitsshares": 197,
    "vestingofearlyexerciseofstockoptions": 4,
    "vestingofearlyexerciseofstockoption": 3000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 13548000,
    "sharebasedcompensation": 13548000,
    "depreciationdepletionandamortization": 210000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 626000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 985000,
    "increasedecreaseinotheroperatingassets": -567000,
    "increasedecreaseinaccountspayable": -361000,
    "increasedecreaseinaccruedliabilities": 1394000,
    "increasedecreaseinleaseliabilities1": -7000,
    "netcashprovidedbyusedinoperatingactivities": -35457000,
    "paymentstoacquirepropertyplantandequipment": 45000,
    "paymentstoacquireshortterminvestments": 70620000,
    "proceedsfromsalematurityandcollectionofshortterminvestments": 16799000,
    "netcashprovidedbyusedininvestingactivities": -53866000,
    "proceedsfromdebtnetofissuancecost": 19986000,
    "proceedsfromissuanceofcommonstock": 2300000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 225000,
    "netcashprovidedbyusedinfinancingactivities": 22542000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -66781000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 36773000,
    "interestpaidnet": 454000,
    "workingcapital": 83700000,
    "percentageofoutstandingcommonstockofcombinedcompany": 0.86,
    "stockholdersequitynotestocksplitconversionratio1": 0.1119,
    "cashcashequivalentsandshortterminvestments": 91000000,
    "thirdpartyservicepercentage": 0.23199999999999998,
    "availableforsaledebtsecuritiesamortizedcostbasis": 69940000,
    "availableforsaledebtsecuritiesgrossunrealizedloss": 178000,
    "debtsecuritiesavailableforsalegainloss": 69762000,
    "cashandcashequivalentsfairvaluedisclosure": 15492000,
    "investmentsfairvaluedisclosure": 34594000,
    "assetsfairvaluedisclosure": 34594000,
    "numberofreportablesegments": 1,
    "debtsecuritiesavailableforsaleaccruedinterestafterallowanceforcreditloss": 100000,
    "debtsecuritiesavailableforsaleaccruedinterestafterallowanceforcreditlossstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "employeerelatedliabilitiescurrent": 2961000,
    "accruedclinicaltrialandcontractexpenses": 3562000,
    "accruedprofessionalfeescurrent": 385000,
    "otheraccruedliabilitiescurrent": 285000,
    "otherassetscurrent": 800000,
    "lineofcreditfacilityborrowingcapacitydescription": "The second tranche of $20.0 million was drawn by the Company on December 29, 2022. The third tranche of $25.0 million remains available at the Company's request subject to the Lenders' discretion. ",
    "debtinstrumentmaturitydate": "November 1, 2026",
    "debtinstrumentinterestrateduringperiod": 0.0815,
    "debtinstrumentinterestratestatedpercentage": 0.11900000000000001,
    "debtinstrumentfinalpaymentinterestfeepercentage": 0.05,
    "prepaymentfeepercentage": 0.02,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 8571000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 8571000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 7858000,
    "aggregateminimumpaymentsunderdebtarrangements": 25000000,
    "unamortizeddiscountoffutureminimumpaymentsunderlongtermdebtarrangement": 123000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedassets": 18956000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedacquiredipranddprojects": 84478000,
    "businesscombinationrecognizedidentifiableassetsacquiredgoodwillandliabilitiesassumednet": 103434000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcashandequivalents": 17143000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcurrentassetsprepaidexpenseandotherassets": 3768000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcurrentliabilitiesaccountspayableandaccruedliabilities": 1955000,
    "sharesissuedpricepershare": 1.46,
    "convertiblepreferredstocksharesissueduponconversion": "null",
    "stockoptionsgranted": "four years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 2.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 449671,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten-year",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four years",
    "sharesissuedconvertiblesharesconvertiblepricepershare": 21,
    "classofwarrantorrightissuedinperiodofwarrantsorrights": 250323,
    "classofwarrantorrightissuedremainunexercised": 86209,
    "classofwarrantorrightexpiryperiodofwarrantsorrights": " seven-year",
    "increaseinauthorizedcapital": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforissuance": 235000,
    "nonrecurringnoncashexpense": 1600000,
    "percentageofnonqualifiedoptionsexercisablepriceoffairmarketvalueofcommonstock": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 30.22,
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "allocatedsharebasedcompensationexpense": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 3,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 600000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonvestedoptionsoutstandingweightedaverageremainingcontractualterm": 2.4,
    "percentageofcommonstockoutstanding": 0.0998,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.039700000000000006,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.8620000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 67000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 3882000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 540000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 2247000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 7201,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.79,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.24,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 6.54,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 6.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 5.57,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 7.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": 8.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 208000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 168000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 483000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 198000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 64000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 3.83,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 3.94,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 8.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": 1.3,
    "operatinglosscarryforwards": 106600000,
    "researchtaxcreditcarryforwards": 2300000,
    "operatinglosscarryforwardsexpirationyearstart": 2030,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "valuationallowancedeferredtaxassetchangeinamount": 11300000,
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 125200000,
    "orphandrugcreditcarryforwards": 10100000,
    "researchcreditcarryforwardsexpirationyearstart": 2027,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 41179000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 9058000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1899000,
    "deferredtaxassetsinprocessresearchanddevelopment": 3829000,
    "section174capitalizedrdexpenditures": 4768000,
    "deferredtaxassetsother": 52000,
    "deferredtaxassetsgross": 60785000,
    "rouasset": -56000,
    "deferredincometaxliabilities": 56000,
    "netdeferredtaxassetsbeforevaluationallowance": 60729000,
    "deferredtaxassetsvaluationallowance": 60729000,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.23,
    "effectiveincometaxrategeneralbusinesscredits": 0.05,
    "effectiveincometaxratereconciliationotheradjustments": -0.03,
    "unrecognizedtaxbenefits": 5781000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 884000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 65000,
    "operatingleaseliability": 278000,
    "operatingleaseexpense": 400000,
    "operatingleaseleaseincomeleasepayments": 400,
    "descriptionoflesseeleasingarrangementsneworamended": "There were no new or amended lease arrangements executed in 2022 or 2021.",
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 284000,
    "lesseeoperatingleaseliabilitypaymentsdue": 284000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 6000,
    "operatingleaseweightedaveragediscountratepercent": 0.08,
    "operatingleaseweightedaverageremainingleaseterm1": 0.7
  },
  {
    "date": "2021-12-30",
    "symbol": "VIRX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "VIRACTA THERAPEUTICS, INC.",
    "entitycentralindexkey": 1061027,
    "entitycurrentreportingstatus": "Yes ",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No ",
    "entityvoluntaryfilers": "No ",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityfilenumber": "000-51531",
    "entitytaxidentificationnumber": "94-3295878",
    "entityaddressaddressline1": "2533 S. Coast Hwy. 101, Suite 210",
    "entityaddresscityortown": "Cardiff",
    "entityaddressstateorprovince": "California",
    "entityaddresspostalzipcode": 92007,
    "cityareacode": 858,
    "localphonenumber": "400-8470",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityinteractivedatacurrent": "Yes ",
    "entityincorporationstatecountrycode": "Delaware",
    "tradingsymbol": "VIRX",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "securityexchangename": "The Nasdaq Stock Market LLC",
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "San Diego, California",
    "auditorfirmid": 42,
    "cashandcashequivalentsatcarryingvalue": 103554000,
    "prepaidexpenseandotherassetscurrent": 1719000,
    "assetscurrent": 105273000,
    "propertyplantandequipmentnet": 242000,
    "operatingleaserightofuseasset": 640000,
    "otherassetsnoncurrent": 2397000,
    "assets": 108552000,
    "accountspayablecurrent": 2901000,
    "accruedliabilitiescurrent": 5802000,
    "operatingleaseliabilitycurrent": 381000,
    "liabilitiescurrent": 9084000,
    "longtermdebtnoncurrent": 4819000,
    "operatingleaseliabilitynoncurrent": 278000,
    "preferredstockvalue": 5452000,
    "commonstockvalue": 4000,
    "additionalpaidincapital": 254592000,
    "retainedearningsaccumulateddeficit": -165677000,
    "stockholdersequity": -165677000,
    "liabilitiesandstockholdersequity": 108552000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": "null",
    "preferredstocksharesissued": 10248,
    "preferredstocksharesoutstanding": 8333,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 23861000,
    "researchanddevelopmentinprocess": 88478000,
    "generalandadministrativeexpense": 15437000,
    "operatingexpenses": 127776000,
    "gainlossonroyaltypurchaseagreementnonoperating": 13500000,
    "operatingincomeloss": -114276000,
    "gainonforgivenessofppploan": 257000,
    "interestincomeother": 38000,
    "interestexpense": 491000,
    "otherexpenses": 290000,
    "othernonoperatingincomeexpense": -486000,
    "netlossandcomprehensiveloss": -114762000,
    "earningspersharebasicanddiluted": -3.6,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "sharesissued": 37425000,
    "stockissuedduringperiodvaluestockoptionsexercised": 339000,
    "stockissuedduringperiodsharesstockoptionsexercised": 301000,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 107000,
    "vestingofearlyexerciseofstockoptions": 4000,
    "vestingofearlyexerciseofstockoption": 3000,
    "stockissuedduringperiodvaluenewissues": 62317000,
    "stockissuedduringperiodsharesnewissues": 12012000,
    "stockissuedduringperiodvalueissuedforservices": 97982000,
    "stockissuedduringperiodsharesissuedforservices": 5173000,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 83302000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 18812000,
    "adjustmentstoadditionalpaidincapitalequitycomponentofconvertibledebt": 396000,
    "stockissuedduringperiodvalueconversionofunits": 5452000,
    "stockissuedduringperiodsharesconversionofunits": 10000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 5542000,
    "netincomeloss": -114762000,
    "acquiredinprocessresearchanddevelopment": 84478000,
    "purchasedinprocessresearchanddevelopment": 4000000,
    "sharebasedcompensation": 5542000,
    "depreciationdepletionandamortization": 178000,
    "changeinfairvalueofpreferredstockwarrantliability": 290000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 1045000,
    "increasedecreaseinotheroperatingassets": -884000,
    "increasedecreaseinaccountspayable": 922000,
    "increasedecreaseinaccruedliabilities": 907000,
    "increasedecreaseinleaseliabilities": 12000,
    "netcashprovidedbyusedinoperatingactivities": -18851000,
    "paymentstoacquirepropertyplantandequipment": 252000,
    "paymentstoacquireinprocessresearchanddevelopment": 4000000,
    "cashacquiredfromacquisition": 17143000,
    "netcashprovidedbyusedininvestingactivities": 12891000,
    "proceedsfromdebtnetofissuancecost": -234000,
    "proceedsfromissuanceofcommonstock": 62320000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 339000,
    "netcashprovidedbyusedinfinancingactivities": 62425000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 56465000,
    "interestpaidnet": 343000,
    "warrantliabilityreclassificationtoequity": 396000,
    "issuanceofconvertiblepreferredstocknoncashtransactionuponmerger": 5452000,
    "conversionofstockamountconverted1": 83302000,
    "issuanceofcommonstocknoncashtransactionuponmerger": 97982000,
    "workingcapital": 96200000,
    "upfrontpaymentreceived": 13500000,
    "fairvalueliabilitiesmeasuredonrecurringbasischangeinunrealizedgainloss": 290000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisreclassifiationtoequity": -396000,
    "moneymarketfundsatcarryingvalue": 14900000,
    "numberofreportablesegments": 1,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "legalfees": 100000,
    "employeerelatedliabilitiescurrent": 1695000,
    "accruedclinicaltrialandcontractexpenses": 3380000,
    "accruedprofessionalfeescurrent": 180000,
    "otheraccruedliabilitiescurrent": 547000,
    "milestonepaymentreceivedinthefuture": 20000000,
    "debtinstrumentmaturitydate": "November 1, 2026",
    "debtinstrumentinterestrateduringperiod": 0.0815,
    "debtinstrumentinterestratestatedpercentage": 0.049,
    "debtinstrumentfinalpaymentinterestfeepercentage": 0.05,
    "prepaymentfeepercentage": 0.02,
    "debtinstrumentfaceamount": 5000000,
    "feeincurredforundrawnportionofloan": 0.03,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 1714000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 1714000,
    "longtermdebtmaturitiesrepaymentsofprincipalafteryearfour": 1572000,
    "aggregateminimumpaymentsunderdebtarrangements": 5000000,
    "unamortizeddiscountoffutureminimumpaymentsunderlongtermdebtarrangement": 181000,
    "businesscombinationconsiderationtransferredincludingequityinterestinacquireeheldpriortocombination1": 103400000,
    "businessacquisitionnumberofsharesoutstandingpriortothemergerdate": "null",
    "businessacquisitionnumberofconvertiblesharesoutstandingpriortothemergerdate": 10248,
    "businessacquisitionnumberofsharesoutstandingonconvertiblebasispriortothemergerdate": 292799,
    "businessacquisitionshareprice": 18.62,
    "businessacquisitioncostofacquiredentitytransactioncosts": 1600000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedassets": 18956000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedacquiredipranddprojects": 84478000,
    "businesscombinationrecognizedidentifiableassetsacquiredgoodwillandliabilitiesassumednet": 103434000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcashandequivalents": 17143000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcurrentassetsprepaidexpenseandotherassets": 3768000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcurrentliabilitiesaccountspayableandaccruedliabilities": 1955000,
    "sharesissuedpricepershare": 3.65,
    "stockoptionsgranted": "four years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 6.25,
    "investmentbankingadvisorybrokerageandunderwritingfeesandcommissions": 40000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofadditionalsharesauthorized": 715000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 60948,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 0.85,
    "durationofofferingperiod": "12-month",
    "durationofeachpurchaseperiod": "6-month",
    "fairvalueofsharesissuableunderemployeestockpurchaseplan": 25000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten-year",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four years",
    "sharesissuedconvertiblesharesconvertiblepricepershare": 21,
    "classofwarrantorrightissuedinperiodofwarrantsorrights": 250323,
    "classofwarrantorrightissuedremainunexercised": 86209,
    "classofwarrantorrightexpiryperiodofwarrantsorrights": " seven-year",
    "preferredstockdividendratepercentage": 0.08,
    "percentageofnonqualifiedoptionsexercisablepriceoffairmarketvalueofcommonstock": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 27.65,
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "allocatedsharebasedcompensationexpense": 700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 3.4,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 2700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonvestedoptionsoutstandingweightedaverageremainingcontractualterm": 3.4,
    "percentageofcommonstockoutstanding": 0.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.013300000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.902,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 88000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 3223000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 852000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 1973000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 8.82,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 8000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.98,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 86000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 7.39,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 3.23,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 829000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionscancelledinperiodintrinsicvalue": 154000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 7.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 745000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 852000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 107000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 4.22,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 4.22,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 4.22,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": 3.4,
    "operatinglosscarryforwards": 105300000,
    "researchtaxcreditcarryforwards": 1800000,
    "operatinglosscarryforwardsexpirationyearstart": 2030,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "valuationallowancedeferredtaxassetchangeinamount": 24600000,
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 107200000,
    "orphandrugcreditcarryforwards": 7300000,
    "researchcreditcarryforwardsexpirationyearstart": 2027,
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 4500000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 37319000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 6674000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 701000,
    "deferredtaxassetsinprocessresearchanddevelopment": 4804000,
    "deferredtaxassetsother": 107000,
    "deferredtaxassetsgross": 49605000,
    "rouasset": -134000,
    "deferredincometaxliabilities": 134000,
    "netdeferredtaxassetsbeforevaluationallowance": 49471000,
    "deferredtaxassetsvaluationallowance": 49471000,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.07,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.09,
    "effectiveincometaxrategeneralbusinesscredits": 0.03,
    "effectiveincometaxrateacquirediprd": -0.21,
    "effectiveincometaxratereconciliationotheradjustments": -0.01,
    "unrecognizedtaxbenefits": 4962000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 991000,
    "operatingleaseliability": 659000,
    "operatingleaseexpense": 608000,
    "operatingleasepayments": 546000,
    "operatingleaseweightedaveragediscountratepercent": 0.08,
    "operatingleaseweightedaverageremainingleaseterm1": 1.6,
    "descriptionoflesseeleasingarrangementsneworamended": "There were no new or amended lease arrangements executed in 2021.",
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 416000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 284000,
    "lesseeoperatingleaseliabilitypaymentsdue": 700000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 41000
  },
  {
    "date": "2020-12-30",
    "symbol": "VIRX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "SUNESIS PHARMACEUTICALS INC.",
    "entitycentralindexkey": 1061027,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "false",
    "entityfilenumber": "000-51531",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "94-3295878",
    "entityaddressaddressline1": "395 Oyster Point Boulevard",
    "entityaddressaddressline2": "Suite 400",
    "entityaddresscityortown": "South San Francisco",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94080,
    "cityareacode": 650,
    "localphonenumber": "266-3500",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "tradingsymbol": "SNSS",
    "securityexchangename": "NASDAQ",
    "cashandcashequivalentsatcarryingvalue": 20410000,
    "prepaidexpenseandotherassetscurrent": 1734000,
    "assetscurrent": 22144000,
    "operatingleaserightofuseasset": 273000,
    "otherassetsnoncurrent": 830000,
    "assets": 23247000,
    "accountspayablecurrent": 479000,
    "accruedclinicalexpensecurrent": 87000,
    "employeerelatedliabilitiescurrent": 1384000,
    "otheraccruedliabilitiescurrent": 1087000,
    "operatingleaseliabilitycurrent": 273000,
    "liabilitiescurrent": 3310000,
    "liabilities": 3310000,
    "preferredstockvalue": 5545000,
    "commonstockvalue": 2000,
    "additionalpaidincapital": 718800000,
    "retainedearningsaccumulateddeficit": -704410000,
    "stockholdersequity": -704410000,
    "liabilitiesandstockholdersequity": 23247000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "preferredstocksharesissued": 10000,
    "preferredstocksharesoutstanding": 8333,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 400000000,
    "commonstocksharesissued": 18108000,
    "commonstocksharesoutstanding": 18108000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 120000,
    "typeofrevenueextensiblelist": "snss:LicenseAndOtherRevenueMember",
    "researchanddevelopmentexpense": 12259000,
    "generalandadministrativeexpense": 10164000,
    "operatingexpenses": 22423000,
    "operatingincomeloss": -22303000,
    "interestexpense": 302000,
    "othernonoperatingincomeexpense": 995000,
    "netincomeloss": -21610000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -1000,
    "comprehensiveincomenetoftax": -21611000,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 14093000,
    "earningspersharebasicanddiluted": -1.53,
    "sharesissued": 18108000,
    "issuanceofcommonstockpreferredstocknetofissuancecost": 12633000,
    "issuanceofcommonstockpreferredstocknetofissuancecostshares": 6000000,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 6224000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 946600,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 48000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 22413,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 1324000,
    "issuanceofcommonstock": 13800000,
    "paymentsofstockissuancecosts": 1167000,
    "profitloss": -21610000,
    "sharebasedcompensation": 1324000,
    "depreciationamortizationandaccretionnet": -41000,
    "amortizationoffinancingcostsanddiscounts": 35000,
    "gainonconversionofnotereceivabletoequityinvestments": 830000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -61000,
    "increasedecreaseinaccountspayable": -312000,
    "increasedecreaseinaccruedclinicalexpense": -434000,
    "increasedecreaseinemployeerelatedliabilities": 399000,
    "increasedecreaseinotheraccruedliabilities": -31000,
    "netcashprovidedbyusedinoperatingactivities": -21439000,
    "paymentstoacquiremarketablesecurities": 747000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 17154000,
    "netcashprovidedbyusedininvestingactivities": 16407000,
    "repaymentsofnotespayable": 5500000,
    "proceedsfromissuanceofcommonstock": 12633000,
    "proceedsfromexerciseofstockoptionsandstockpurchaserights": 48000,
    "netcashprovidedbyusedinfinancingactivities": 7181000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 2149000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 20410000,
    "interestpaidnet": 339000,
    "conversionofstockamountconverted1": 6224000,
    "conversionofnotesreceivabletoequityinvestments": 830000,
    "stockholdersequityreversestocksplit": "one-for-ten",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "2020-03-31",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "changeinaccountingprincipleaccountingstandardsupdateearlyadoption": "true",
    "numberofreportablesegments": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 0.85,
    "measurementdatesoffairmarketvalueforemployeestockpurchaseplanpurchases": "At the beginning of a 12-month offering period or at the end of one of the two related six-month purchase periods.",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1724000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 19504000,
    "availableforsalesecuritiesdebtsecurities": 19504000,
    "accruedoutsideservicefeescurrent": 299000,
    "accruedprofessionalfeescurrent": 624000,
    "otheraccrualscurrent": 164000,
    "numberoflawsuitsfileduponmergeragreement": 9,
    "losscontingencylawsuitfilingdate": "January 8, 2021",
    "sharesissuedpricepershare": 600,
    "conversionofstocksharesconverted1": 8085,
    "convertiblepreferredstocksharesissueduponconversion": 100,
    "percentageofcommonstockoutstanding": 0.0998,
    "preferredstockpaymenttostockholdersineventofliquidationdissolutionorwindinguppreferencepershare": 0.0001,
    "preferredstockvotingrights": "Shares of Series E and Series F Stock will generally have no voting rights, except as required by law and except that the consent of holders of a majority of the outstanding Series E Stock will be required to amend the terms of the Series E and Series F Stock.",
    "commonstockvotingrights": "one vote per share",
    "agreementsdate": "2011-08",
    "agreementamendeddatetwo": "2017-11",
    "terminationdate": "2020-06-25",
    "optionexercisableonfirstanniversaryofvestingcommencementdatepercent": 0.25,
    "portionofoptionexercisableforeachmonthovervestingpercent": 0.04166,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P1Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "Continuing non-employee members of the board of directors, of which 1/24th of the shares subject to such options become exercisable each month following the date of grant over a two-year vesting period",
    "commonstockavailableforissuanceautomaticincreaseperiod": "P10Y",
    "commonstockavailableforissuanceautomaticincreasemaximumnumberofshares": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 337000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 431000,
    "durationofofferingperiod": "P12M",
    "numberofpurchaseperiodsineachofferingperiod": 2,
    "durationofeachpurchaseperiod": "P6M",
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 21000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 32.45,
    "classofwarrantsorrightsexpirationyearandmonth": "2021-03",
    "sharebasedcompensationarrangementoutstandingsecurities": 1724000,
    "commonstockcapitalsharesreservedforfutureissuance": 2155000,
    "allocatedsharebasedcompensationexpense": 1324000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P4Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.181,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.004,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.36,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgrantdatefairvalue": 166000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 1200000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 700000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 678000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 175000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 678000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 508000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 20.23,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 4.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 8.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 20.23,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 24.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y11M23D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P6Y11M23D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y3M21D",
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -21609000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -21609000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "valuationallowancedeferredtaxassetchangeinamount": 4100000,
    "operatinglosscarryforwards": 335000000,
    "researchtaxcreditcarryforwards": 8900000,
    "operatinglosscarryforwardsexpirationyearstart": 2028,
    "unrecognizedtaxbenefits": 1865000,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.075,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.006,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": 0.013,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.191,
    "effectiveincometaxratereconciliationexpirednolsresearchanddevelopmentcreditsandothercarryforwards": -0.098,
    "effectiveincometaxratereconciliationnonqualifiedstockoptioncancellations": -0.003,
    "deferredtaxassetsoperatinglosscarryforwards": 123313000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 15235000,
    "deferredtaxassetscapitalizedresearchcost": 5772000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 4110000,
    "deferredtaxassetsleaseliabilities": 76000,
    "deferredtaxassetspropertyplantandequipment": 74000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 4000,
    "deferredtaxassetsgross": 148584000,
    "deferredtaxliabilitiesrightofuseassets": 76000,
    "deferredincometaxliabilities": 76000,
    "deferredtaxassetsnetbeforevaluationallowance": 148508000,
    "deferredtaxassetsvaluationallowance": 148508000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 55000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 37000,
    "operatingleaseagreementdate": "2014-01",
    "leaseexpirationdate1": "2021-06-30",
    "operatingleaseagreementamendeddate": "2017-12",
    "lesseeoperatingleasedescription": "The lease was last amended in December 2017 to extend the expiration date to June 30, 2021, with an option to extend the lease for two additional years. The Company did not assume the option to extend the lease term for two additional years in its determination of the lease term as the exercise of the option was not reasonably certain when the lease was last amended in December 2017.",
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseoptiontoextend": "option to extend the lease for two additional years.",
    "lesseeoperatingleaserenewalterm": "P2Y",
    "lesseeoperatingleaseremainingterm": "P6M",
    "operatingleasepayments": 600000,
    "leaseandrentalexpense": 600000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 294000,
    "lesseeoperatingleaseliabilitypaymentsdue": 294000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 21000,
    "operatingleaseliability": 273000
  },
  {
    "date": "2019-12-30",
    "symbol": "VIRX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "SUNESIS PHARMACEUTICALS INC.",
    "entitycentralindexkey": 1061027,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityfilenumber": "000-51531",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "94-3295878",
    "entityaddressaddressline1": "395 Oyster Point Boulevard",
    "entityaddressaddressline2": "Suite 400",
    "entityaddresscityortown": "South San Francisco",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94080,
    "cityareacode": 650,
    "localphonenumber": "266-3500",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "tradingsymbol": "SNSS",
    "securityexchangename": "NASDAQ",
    "cashandcashequivalentsatcarryingvalue": 12761000,
    "restrictedcashcurrent": 5500000,
    "marketablesecuritiescurrent": 16364000,
    "prepaidexpenseandotherassetscurrent": 1697000,
    "assetscurrent": 36322000,
    "propertyplantandequipmentnet": 3000,
    "operatingleaserightofuseasset": 817000,
    "otherassetsnoncurrent": 98000,
    "assets": 37240000,
    "accountspayablecurrent": 791000,
    "accruedclinicalexpensecurrent": 521000,
    "employeerelatedliabilitiescurrent": 985000,
    "otheraccruedliabilitiescurrent": 1109000,
    "notespayablecurrent": 5465000,
    "operatingleaseliabilitycurrent": 545000,
    "liabilitiescurrent": 9416000,
    "otherliabilitiesnoncurrent": 9000,
    "operatingleaseliabilitynoncurrent": 272000,
    "liabilities": 9697000,
    "preferredstockvalue": 11769000,
    "commonstockvalue": 11000,
    "additionalpaidincapital": 698562000,
    "accumulatedothercomprehensiveincomelossnetoftax": 1000,
    "retainedearningsaccumulateddeficit": -682800000,
    "stockholdersequity": -682800000,
    "liabilitiesandstockholdersequity": 37240000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "preferredstocksharesissued": 20000,
    "preferredstocksharesoutstanding": 8333,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 400000000,
    "commonstocksharesissued": 111393000,
    "commonstocksharesoutstanding": 111393000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 2073000,
    "typeofrevenueextensiblelist": "snss:LicenseAndOtherRevenueMember",
    "researchanddevelopmentexpense": 15412000,
    "generalandadministrativeexpense": 9949000,
    "operatingexpenses": 25361000,
    "operatingincomeloss": -23288000,
    "interestexpense": 514000,
    "othernonoperatingincomeexpense": 472000,
    "netincomeloss": -23331000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": 1000,
    "comprehensiveincomenetoftax": -23329000,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 87129000,
    "earningspersharebasicanddiluted": -0.27,
    "sharesissued": 111393000,
    "issuanceofcommonstockpreferredstocknetofissuancecost": 44604000,
    "issuanceofcommonstockpreferredstocknetofissuancecostshares": 61333000,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 21761000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 11950165,
    "issuanceofcommonstockthroughcontrolledequityofferingfacilitiesnetofissuancecosts": 464000,
    "issuanceofcommonstockthroughcontrolledequityofferingfacilitiesnetofissuancecostsshares": 398000,
    "stockissuedduringperiodvaluerestrictedstockawardgross": 54000,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 104000,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 63000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 133322,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 1695000,
    "issuanceofcommonstock": 38000000,
    "issuanceofpreferredstock": 10000000,
    "paymentsofstockissuancecosts": 3400000,
    "issuanceofcommonstockthroughequityfacilitiesgrossproceeds": 473000,
    "issuanceofcommonstockthroughequityfacilitiesissuancecost": 9000,
    "profitloss": -23330000,
    "sharebasedcompensation": 1749000,
    "depreciationamortizationandaccretionnet": -70000,
    "amortizationoffinancingcostsanddiscounts": 116000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 294000,
    "increasedecreaseinaccountspayable": -602000,
    "increasedecreaseinaccruedclinicalexpense": 21000,
    "increasedecreaseinemployeerelatedliabilities": 42000,
    "increasedecreaseinotheraccruedliabilities": 183000,
    "netcashprovidedbyusedinoperatingactivities": -22185000,
    "paymentstoacquiremarketablesecurities": 20035000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 3750000,
    "netcashprovidedbyusedininvestingactivities": -16285000,
    "proceedsfromnotespayable": 5453000,
    "repaymentsofnotespayable": 7500000,
    "proceedsfromissuanceofconvertiblepreferredstock": 12533000,
    "proceedsfromissuanceofcommonstock": 500000,
    "proceedsfromissuanceofcommonstockthroughequityfacilitiesnet": 464000,
    "proceedsfromexerciseofstockoptionsandstockpurchaserights": 63000,
    "netcashprovidedbyusedinfinancingactivities": 43035000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 4565000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 18261000,
    "interestpaidnet": 695000,
    "conversionofstockamountconverted1": 21762000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 1362000,
    "potentialprecommercializationpaymentsreceivable": 57000000,
    "potentialregulatoryandcommercialmilestonemaximumpaymentreceivable": 57000000,
    "cashandcashequivalentsrestrictedcashandmarketablesecurities": 34600000,
    "securitiespolicymaturitylimitperiod": "P24M",
    "securitiespolicydollarweightedaveragematuritylimitperiod": "P12M",
    "operatingleaseliability": 817000,
    "lesseeoperatingleaseliabilitypaymentsdue": 873000,
    "numberofreportablesegments": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 0.85,
    "measurementdatesoffairmarketvalueforemployeestockpurchaseplanpurchases": "At the beginning of a 12-month offering period or at the end of one of the two related six-month purchase periods.",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 25088000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 26656000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 1000,
    "availableforsalesecuritiesdebtsecurities": 26657000,
    "cashequivalentsatcarryingvalue": 10293000,
    "cashandcashequivalentsfairvaluedisclosure": 10293000,
    "marketablesecuritiesamortizedcost": 16363000,
    "marketablesecuritiesgrossunrealizedgains": 1000,
    "accruedoutsideservicefeescurrent": 690000,
    "accruedprofessionalfeescurrent": 220000,
    "interestpayablecurrent": 57000,
    "deferredrevenuecurrent": 120000,
    "otheraccrualscurrent": 22000,
    "potentialprecommercializationpaymentspayable": 9200000,
    "regulatorycommercialmilestonespaymentsanddoubledigitroyaltypaymentsreceivable": 57000000,
    "contractwithcustomerliability": 100000,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 179000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 2888000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 3018000,
    "aggregateminimumpaymentsunderdebtarrangements": 6085000,
    "interestportionoffutureminimumpaymentsunderlongtermdebtarrangement": 585000,
    "notespayable": 5500000,
    "unamortizeddebtdiscountandissuancecosts": 35000,
    "sharesissuedpricepershare": 1.19,
    "convertiblepreferredstocksharesissueduponconversion": 1000,
    "percentageofcommonstockoutstanding": 0.0998,
    "preferredstockpaymenttostockholdersineventofliquidationdissolutionorwindinguppreferencepershare": 0.0001,
    "preferredstockvotingrights": "Shares of Series D, Series E, and Series F Stock will generally have no voting rights, except as required by law and except that the consent of holders of a majority of the outstanding Series D and Series E Stock will be required to amend the terms of the Series D, Series E, and Series F Stock.",
    "conversionofstocksharesconverted1": 7000,
    "commonstockvotingrights": "One vote per share",
    "agreementsdate": "2011-08",
    "agreementamendeddatetwo": "2017-11",
    "stockissuedduringperiodsharesnewissues": 400000,
    "proceedsfromissuanceofcommonstockgross": 500000,
    "commonstocksharessubscriptions": 43100000,
    "stockpurchaseagreementremainingpurchasecommitment": 10900000,
    "optionexercisableonfirstanniversaryofvestingcommencementdatepercent": 0.25,
    "portionofoptionexercisableforeachmonthovervestingpercent": 0.04166,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P1Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "Continuing non-employee members of the board of directors, of which 1/24th of the shares subject to such options become exercisable each month following the date of grant over a two-year vesting period",
    "commonstockavailableforissuanceautomaticincreaseperiod": "P10Y",
    "commonstockavailableforissuanceautomaticincreasemaximumnumberofshares": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1716000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1422000,
    "durationofofferingperiod": "P12M",
    "numberofpurchaseperiodsineachofferingperiod": 2,
    "durationofeachpurchaseperiod": "P6M",
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 218000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 3.25,
    "classofwarrantsorrightsexpirationyearandmonth": "2021-03",
    "sharebasedcompensationarrangementoutstandingsecurities": 25088000,
    "commonstockcapitalsharesreservedforfutureissuance": 26510000,
    "allocatedsharebasedcompensationexpense": 1749000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P4Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.142,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.017,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 0.56,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgrantdatefairvalue": 292000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 1600000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 2000000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 5156000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 720000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 5156000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 3151000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.73,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 3.27,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 2.73,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 3.56,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y2M8D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P8Y2M8D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y8M23D",
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -23330000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -23330000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "valuationallowancedeferredtaxassetchangeinamount": 4900000,
    "operatinglosscarryforwards": 310700000,
    "researchtaxcreditcarryforwards": 8700000,
    "operatinglosscarryforwardsexpirationyearstart": 2028,
    "unrecognizedtaxbenefits": 1847000,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.071,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.006,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": 0.013,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.209,
    "effectiveincometaxratereconciliationexpirednolsresearchanddevelopmentcreditsandothercarryforwards": -0.069,
    "effectiveincometaxratereconciliationnonqualifiedstockoptioncancellations": -0.01,
    "deferredtaxassetsoperatinglosscarryforwards": 119015000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 15140000,
    "deferredtaxassetscapitalizedresearchcost": 6081000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 3996000,
    "deferredtaxassetsleaseliabilities": 152000,
    "deferredtaxassetspropertyplantandequipment": 77000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 86000,
    "deferredtaxassetsgross": 144547000,
    "deferredtaxliabilitiesrightofuseassets": 152000,
    "deferredincometaxliabilities": 152000,
    "deferredtaxassetsnetbeforevaluationallowance": 144395000,
    "deferredtaxassetsvaluationallowance": 144395000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 58000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 23000,
    "operatingleaseagreementdate": "2014-01",
    "leaseexpirationdate1": "2021-06-30",
    "operatingleaseagreementamendeddate": "2017-12",
    "lesseeoperatingleasedescription": "The lease was last amended in December 2017 to extend the expiration date to June 30, 2021, with an option to extend the lease for two additional years. The Company did not assume the option to extend the lease term for two additional years in its determination of the lease term as the exercise of the option was not reasonably certain when the lease was last amended in December 2017.",
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseoptiontoextend": "option to extend the lease for two additional years.",
    "lesseeoperatingleaserenewalterm": "P2Y",
    "lesseeoperatingleaseremainingterm": "P1Y6M",
    "operatingleasepayments": 600000,
    "operatingleasepaymentsuse": 1400000,
    "leaseandrentalexpense": 600000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 579000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 294000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 56000
  }
]